Galmed Pharmaceuticals Ltd. buy Barclays PLC
Start price
24.02.25
/
50%
€6.40
Target price
24.02.26
€98.39
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 24.02.26. The prediction end date can be changed by Barclays_PLC at any time.Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | - | - |
iShares Core DAX® | -0.347% | -0.149% |
iShares Nasdaq 100 | -0.687% | 1.850% |
iShares Nikkei 225® | -2.075% | 3.770% |
iShares S&P 500 | 0.351% | 1.988% |
Comments by Barclays_PLC for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Barclays PLC from $100.00 to $103.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
08.08.24
08.08.24
€85.19
08.08.25
08.08.25
2270.37%
09.08.25
09.08.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.40
09.05.24
09.05.24
€78.88
09.05.25
09.05.25
1516.16%
10.05.25
10.05.25